Akın Çakır

Akın Çakır

Auto-generated profile, based on publicly available information

Akın Çakır

University of Health Sciences Türkiye, İstanbul Prof. Dr. Cemil Taşcıoğlu City Hospital, Clinic of Ophthalmology, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2017 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
AÇAkın Çakır
Akın Çakır
EDEyüp Düzgün
Eyüp Düzgün
SDSerkan Demir
Serkan Demir
YÇYavuz Çakır
Yavuz Çakır
MÜMelih Hamdi Ünal
Melih Hamdi Ünal
To evaluate the effect of carotid artery disease on retinal morphology by means of spectral domain optical coherence tomography (SD-OCT). We examined 23 eyes with internal carotid artery (ICA) stenosis and 24 age- and gender-matched healthy eyes as a control group in this prospective, case-control study. Compherensive ophthalmic examination and SD-OCT scan were performed to all the patients. The average RNFL and macular thicknesses (MT) in the nine macular ETDRS areas were the major OCT measurements for our study. Although all of the average RNFL and MT measurements were lower in the ICA stenosis group, only the total MT and outer ETDRS area (temporal/superior/nasal/inferior outer macula) values were found to be significantly thinner compared to the control group (p=0.004, p=0.009, p<0.001, p=0.002, and p=0.001, respectively). In addition to our knowledge about the effects of ICA stenosis on the retino-choroidal circulation, we found that OCT measurements may be beneficial in the early detection of ocular damage due to ICA stenosis.

19 December 2017 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
GMGamze Maden
Gamze Maden
ACAkin Cakir
Akin Cakir
DIDilan Icar
Dilan Icar
BEBurak Erden
Burak Erden
SBSelim Bolukbasi
Selim Bolukbasi
MEMustafa Elcioglu
Mustafa Elcioglu
Purpose. To evaluate the effects of age and sex on the photoreceptor outer segment (PROS) length in healthy eyes, using spectral-domain optical coherence tomography (SD-OCT). Methods. A total of 97 eyes of 97 healthy participants (spherical equivalent < ±1 diopters [D]) were scanned with SD-OCT. The patients were divided into 3 groups by age: group 1 (0–20 years), group 2 (21–40 years), and group 3 (41–60 years). The PROS length was defined as the distance from the inner surface of IS/OS (inner segment/outer segment) band to the inner surface of retinal pigment epithelium (RPE). Results. The mean PROS length was 52.01 ± 3.79 μm in females and 53.41 ± 3.37 μm in males (p=0.061). The mean PROS length of the different groups was 53.70 ± 3.18 μm (0–20 years), 52.14 ± 3.64 μm (21–40 years), and 52.20 ± 3.95 μm (41–60 years) (p=0.155; ANOVA test). Multiple linear regression analysis revealed a −0.039 μm decline in PROS length per year (p=0.074) and a −1.408 μm decline in females (p=0.055). Conclusion. The difference in PROS length was not statistically significant neither for age nor for gender; females tended to have a lower PROS length than males, and PROS length was slightly higher in the first two decades of life.

14 August 2019 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
BEBurak Erden
Burak Erden
AÇAkın Çakır
Akın Çakır
AAAli Cihat Aslan
Ali Cihat Aslan
SBSelim Bölükbaşı
Selim Bölükbaşı
MEMustafa Nuri Elçioğlu
Mustafa Nuri Elçioğlu
Purpose: To evaluate the efficacy and safety of posterior 40 mg subtenon triamcinolone acetonide (PST) injection in treating Irvine-Gass syndrome. Methods: The retrospective study included 21 patients (mean age: 76 ± 8.2) with a treatment-naïve eye subjected to topical anesthesia and injection of 40 mg/ml triamcinolone via a blunt tip SubTenon cannula through a single inferonasal peritomy. Best corrected visual acuity (BCVA; logMAR), intraocular pressure (IOP), biomicroscopic and funduscopic findings, and optical coherence tomography (OCT) measurements were recorded. Results: Baseline central macular thickness decreased from 431 ± 136 µm to 300 ± 67 µm (1st month; p = .002), to 292 ± 56 µm (3rd month; p = .002), and to 299 ± 66 µm (6th month; p = .005). Mean BCVA increased from 0.71 ± 0.23 to 0.27 ± 0.11, 0.19 ± 0.06, and 0.24 ± 0.17, respectively (all visits; p < 0.001). Mean IOP values did not change significantly (p = .12). Conclusion: PST injection is an effective and safe treatment for Irvine-Gass syndrome.

18 September 2018 in International Journal of Ophthalmology
Verified
Journal Article
Open access
ABAlper Halil Bayat
Alper Halil Bayat
AÇAkın Çakır
Akın Çakır
ŞGŞeyma G
Şeyma G
SBSelim Böl
Selim Böl
BEBurak Erden
Burak Erden
MEMustafa Nuri Elçioğlu
Mustafa Nuri Elçioğlu
AIM: To compare three initial monthly intravitreal ranibizumab (IVR) injections followed by pro re nata (PRN) dosing with one initial monthly IVR injections followed by PRN dosing for macular edema (ME) secondary to branch retinal vein occlusion (BRVO). METHODS: Forty-two eyes of 42 patients who had IVR injections for BRVO were retrospectively studied. Eighteen eyes received 1 initial IVR injection (1+PRN group) and 24 eyes received 3 monthly IVR injections (3+PRN). At 1, 3, 6 and 12mo; spectral-domain optical coherence tomography (SD-OCT) was performed. Central macular thickness (CMT), the integrity of the external limiting membrane (ELM), the presence of subretinal fluid, cyst size, the presence of inner segment/outer segment (IS/OS) defect were determined. RESULTS: At baseline the mean CMT was 521.3 +/- 153.2 mu m in the 3+PRN group while it was 438.1 +/- 162.4 mu m in 1+PRN group. At the final visit, mean CMT was 278.3 +/- 87.8 mu m in the 3+PRN group and 285.2 +/- 74.2 mu m in the 1+PRN group (P=0.079). The changes in CMT over the entire study period were also comparable in both groups (243 +/- 160 mu m in the 3+PRN group, and 152.9 +/- 175.3 mu m in the 1+PRN group; P= 0.090). At baseline, best-corrected visual acuity (BCVA) was 0.92 +/- 0.60 logarithm of the minimal angle of resolution (logMA R) in the 3+PRN group, while it was 0.72 +/- 0.46 logMA R in the 1+PRN group. Final BCVA was 0.42 +/- 0.55 logmar in the 3+PRN group and 0.38 +/- 0.50 logmar in the 1+PRN group (P=0.979). Additionally, the BCVA changes from baseline to final visit were not significantly different (-0.50 +/- 0.45 logMA R in the 3+PRN group, and -0.33 +/- 0.39 logMA R in the 1+PRN group; P=0.255). CONCLUSION : No significant differences in the anatomical or functional results are found between 3+PRN and 1+PRN regimens in the patients receiving ranibizumab for ME secondary to BRVO. Intact IS/OS and baseline BCVA are good predictor of the visual gain, while baseline CMT is a good predictor of the anatomical gain.

1 September 2019 in Journal Français d'Ophtalmologie
Verified
Journal Article
Closed access
ACA. Cakir
A. Cakir
BEB. Erden
B. Erden
SBS. Bolukbasi
S. Bolukbasi
AAA. Aydin
A. Aydin
SOS. Yurttaser Ocak
S. Yurttaser Ocak
MEM.N. Elcioglu
M.N. Elcioglu

1 April 2019 in Eye
Verified
Journal Article
Closed access
PDF file
ACAkin Cakir
Akin Cakir
ŞOŞeyma Gulcenur Ozturan
Şeyma Gulcenur Ozturan
DYDilan Yildiz
Dilan Yildiz
BEBurak Erden
Burak Erden
SBSelim Bolukbasi
Selim Bolukbasi
MEMustafa Nuri Elcioglu
Mustafa Nuri Elcioglu